Rafarma Pharmaceuticals Stock Price History
RAFA Stock | USD 0.09 0.03 47.54% |
If you're considering investing in Rafarma Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Rafarma Pharmaceuticals stands at 0.09, as last reported on the 16th of December 2024, with the highest price reaching 0.09 and the lowest price hitting 0.08 during the day. Rafarma Pharmaceuticals is out of control given 3 months investment horizon. Rafarma Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.16, which implies the firm had a 0.16% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 2.34% are justified by taking the suggested risk. Use Rafarma Pharmaceuticals Semi Deviation of 9.7, risk adjusted performance of 0.0948, and Coefficient Of Variation of 850.13 to evaluate company specific risk that cannot be diversified away.
Rafarma Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Rafarma |
Sharpe Ratio = 0.1561
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | RAFA | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
15.02 actual daily | 96 96% of assets are less volatile |
Expected Return
2.34 actual daily | 46 54% of assets have higher returns |
Risk-Adjusted Return
0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Rafarma Pharmaceuticals is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rafarma Pharmaceuticals by adding it to a well-diversified portfolio.
Rafarma Pharmaceuticals Pink Sheet Price History Chart
There are several ways to analyze Rafarma Stock price data. The simplest method is using a basic Rafarma candlestick price chart, which shows Rafarma Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 30, 2024 | 0.12 |
Lowest Price | October 7, 2024 | 0.033 |
Rafarma Pharmaceuticals December 16, 2024 Pink Sheet Price Synopsis
Various analyses of Rafarma Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Rafarma Pink Sheet. It can be used to describe the percentage change in the price of Rafarma Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Rafarma Pink Sheet.Rafarma Pharmaceuticals Price Rate Of Daily Change | 1.48 | |
Rafarma Pharmaceuticals Price Daily Balance Of Power | 2.90 | |
Rafarma Pharmaceuticals Accumulation Distribution | 3,306 | |
Rafarma Pharmaceuticals Price Action Indicator | 0.02 |
Rafarma Pharmaceuticals December 16, 2024 Pink Sheet Price Analysis
Rafarma Pink Sheet Price History Data
The price series of Rafarma Pharmaceuticals for the period between Tue, Sep 17, 2024 and Mon, Dec 16, 2024 has a statistical range of 0.09 with a coefficient of variation of 40.25. The price distribution for the period has arithmetic mean of 0.07. The median price for the last 90 days is 0.07. The company completed stock split (1:10) on 20th of November 2012.Open | High | Low | Close | Volume | ||
12/16/2024 | 0.08 | 0.09 | 0.08 | 0.09 | 29,755 | |
12/13/2024 | 0.06 | 0.08 | 0.06 | 0.06 | 11,925 | |
12/12/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 1.00 | |
12/11/2024 | 0.06 | 0.07 | 0.06 | 0.07 | 15,900 | |
12/10/2024 | 0.06 | 0.09 | 0.06 | 0.08 | 6,300 | |
12/09/2024 | 0.08 | 0.08 | 0.06 | 0.06 | 7,700 | |
12/06/2024 | 0.08 | 0.1 | 0.08 | 0.08 | 22,320 | |
12/05/2024 | 0.08 | 0.08 | 0.08 | 0.08 | 5,000 | |
12/04/2024 | 0.08 | 0.1 | 0.08 | 0.09 | 21,000 | |
12/03/2024 | 0.08 | 0.1 | 0.08 | 0.1 | 13,900 | |
12/02/2024 | 0.09 | 0.09 | 0.09 | 0.09 | 1,000.00 | |
11/29/2024 | 0.09 | 0.09 | 0.09 | 0.09 | 1.00 | |
11/27/2024 | 0.09 | 0.1 | 0.09 | 0.09 | 15,000 | |
11/26/2024 | 0.09 | 0.09 | 0.09 | 0.09 | 10,000 | |
11/25/2024 | 0.1 | 0.1 | 0.09 | 0.09 | 29,798 | |
11/22/2024 | 0.1 | 0.1 | 0.1 | 0.1 | 1.00 | |
11/21/2024 | 0.1 | 0.1 | 0.09 | 0.1 | 8,300 | |
11/20/2024 | 0.1 | 0.1 | 0.09 | 0.09 | 14,200 | |
11/19/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 1.00 | |
11/18/2024 | 0.1 | 0.12 | 0.1 | 0.12 | 11,200 | |
11/15/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 1.00 | |
11/14/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 1,100 | |
11/13/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 5,300 | |
11/12/2024 | 0.09 | 0.11 | 0.09 | 0.11 | 24,700 | |
11/11/2024 | 0.07 | 0.12 | 0.07 | 0.1 | 2,900 | |
11/08/2024 | 0.11 | 0.11 | 0.09 | 0.09 | 17,100 | |
11/07/2024 | 0.11 | 0.12 | 0.11 | 0.12 | 13,000 | |
11/06/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 5,100 | |
11/05/2024 | 0.12 | 0.12 | 0.11 | 0.11 | 82,400 | |
11/04/2024 | 0.11 | 0.12 | 0.10 | 0.12 | 103,700 | |
11/01/2024 | 0.12 | 0.12 | 0.11 | 0.11 | 20,400 | |
10/31/2024 | 0.12 | 0.12 | 0.10 | 0.11 | 121,800 | |
10/30/2024 | 0.1 | 0.12 | 0.08 | 0.12 | 104,000 | |
10/29/2024 | 0.09 | 0.09 | 0.09 | 0.09 | 2,500 | |
10/28/2024 | 0.10 | 0.10 | 0.07 | 0.07 | 33,362 | |
10/25/2024 | 0.07 | 0.10 | 0.06 | 0.10 | 29,100 | |
10/24/2024 | 0.06 | 0.07 | 0.06 | 0.07 | 21,400 | |
10/23/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 1.00 | |
10/22/2024 | 0.07 | 0.07 | 0.06 | 0.06 | 74,930 | |
10/21/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 31,600 | |
10/18/2024 | 0.06 | 0.07 | 0.06 | 0.07 | 20,000 | |
10/17/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 13,000 | |
10/16/2024 | 0.06 | 0.06 | 0.06 | 0.06 | 91,500 | |
10/15/2024 | 0.06 | 0.07 | 0.06 | 0.06 | 16,400 | |
10/14/2024 | 0.06 | 0.06 | 0.04 | 0.06 | 69,200 | |
10/11/2024 | 0.04 | 0.06 | 0.04 | 0.06 | 152,637 | |
10/10/2024 | 0.03 | 0.04 | 0.03 | 0.04 | 1,000.00 | |
10/09/2024 | 0.04 | 0.04 | 0.03 | 0.04 | 10,000 | |
10/08/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 5,344 | |
10/07/2024 | 0.03 | 0.03 | 0.03 | 0.03 | 4,000 | |
10/04/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 4,000 | |
10/03/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
10/02/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
10/01/2024 | 0.03 | 0.04 | 0.03 | 0.04 | 3,800 | |
09/30/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
09/27/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
09/26/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
09/25/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
09/24/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
09/23/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 4,000 | |
09/20/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 4,000 |
About Rafarma Pharmaceuticals Pink Sheet history
Rafarma Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rafarma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rafarma Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rafarma Pharmaceuticals stock prices may prove useful in developing a viable investing in Rafarma Pharmaceuticals
Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. D. RAFARMA PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Rafarma Pharmaceuticals Pink Sheet Technical Analysis
Rafarma Pharmaceuticals technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
All Next | Launch Module |
Rafarma Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rafarma Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Rafarma Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rafarma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0948 | |||
Jensen Alpha | 1.65 | |||
Total Risk Alpha | (0.11) | |||
Sortino Ratio | 0.1054 | |||
Treynor Ratio | 2.48 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Rafarma Pink Sheet analysis
When running Rafarma Pharmaceuticals' price analysis, check to measure Rafarma Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rafarma Pharmaceuticals is operating at the current time. Most of Rafarma Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rafarma Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rafarma Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rafarma Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |